Syngene Q1 Profit Surges 59% YoY

  Published 8 months ago

Biocon’s Syngene posts 59% YoY rise in Q1 FY26 profit to ₹87 crore, driven by contract wins and operational efficiency.

  • Revenue rose 11% YoY to ₹875 crore; EBITDA up 19% to ₹224 crore with margin at 25%.
  • Growth led by pilot-to-contract conversions in research services and expansion in biologics operations in India and the U.S.
  • USFDA inspections cleared; over 20 audits affirm quality; Chethan Yogesh named new compliance officer from July 23.

You might like these

INAR.NS Faces Insolvency Case Over 2.19B Rupees Debt

AbhiBus Launches ‘New Buses’ Filter

Petronet Q1 Profit Falls 25% YoY

India Inflation May Stay Below 3.7%

KPI Green Wins Gujarat Wind Project

Tesla Sales Dip in Italy & Europe

Castrol Wins ₹4,131 Cr Tax Case

News that matters the most ⚡